Advanced search
Publication Cover
Infection and Drug Resistance Volume 14, 2021 - Issue
Submit an article Journal homepage
170
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Foscarnet Therapy for Pure Red Cell Aplasia Related to Human Parvovirus B19 Infection in Kidney Transplant Recipients: A Preliminary Exploration

Yedong Yu1 Department of Kidney Disease Center, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
,
Ruijie Bao1 Department of Kidney Disease Center, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
,
Junhao Lyu1 Department of Kidney Disease Center, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Department of Kidney Disease Immunology Laboratory, State Administration of Traditional Chinese Medicine of China, Hangzhou, People’s Republic of China;3 Department of Key Laboratory of Multiple Organ Transplantation, Ministry of Health of China, Hangzhou, People’s Republic of China;4 Institute of Nephropathy, Zhejiang University, Hangzhou, People’s Republic of China
,
Jianyong Wu1 Department of Kidney Disease Center, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Department of Kidney Disease Immunology Laboratory, State Administration of Traditional Chinese Medicine of China, Hangzhou, People’s Republic of China;3 Department of Key Laboratory of Multiple Organ Transplantation, Ministry of Health of China, Hangzhou, People’s Republic of China;4 Institute of Nephropathy, Zhejiang University, Hangzhou, People’s Republic of China
,
Jianghua Chen1 Department of Kidney Disease Center, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Department of Kidney Disease Immunology Laboratory, State Administration of Traditional Chinese Medicine of China, Hangzhou, People’s Republic of China;3 Department of Key Laboratory of Multiple Organ Transplantation, Ministry of Health of China, Hangzhou, People’s Republic of China;4 Institute of Nephropathy, Zhejiang University, Hangzhou, People’s Republic of China
&
Wenhan Peng1 Department of Kidney Disease Center, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Department of Kidney Disease Immunology Laboratory, State Administration of Traditional Chinese Medicine of China, Hangzhou, People’s Republic of China;3 Department of Key Laboratory of Multiple Organ Transplantation, Ministry of Health of China, Hangzhou, People’s Republic of China;4 Institute of Nephropathy, Zhejiang University, Hangzhou, People’s Republic of ChinaCorrespondence[email protected]
Pages 2911-2923 | Published online: 27 Jul 2021

References

  • Waldman M, Kopp JB. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol. 2007;2(Suppl 1):S47–56. doi:10.2215/CJN.0106030717699510
  • Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet. 1975;1(7898):72–73. doi:10.1016/s0140-6736(75)91074-046024
  • Servant-Delmas A, Morinet F. Update of the human parvovirus B19 biology. Transfus Clin Biol. 2016;23(1):5–12. doi:10.1016/j.tracli.2015.11.00626778837
  • Kurtzman GJ, Cohen B, Meyers P, Amunullah A, Young NS. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet. 1988;2(8621):1159–1162. doi:10.1016/s0140-6736(88)90233-42903376
  • Frickhofen N, Chen ZJ, Young NS, Cohen BJ, Heimpel H, Abkowitz JL. Parvovirus B19 as a cause of acquired chronic pure red cell aplasia. Br J Haematol. 1994;87(4):818–824. doi:10.1111/j.1365-2141.1994.tb06743.x7986722
  • Ammus SS, Yunis AA. Acquired pure red cell aplasia. Am J Hematol. 1987;24(3):311–326. doi:10.1002/ajh.28302403123103428
  • Alangaden GJ, Thyagarajan R, Gruber SA, et al. Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transplant. 2006;20(4):401–409. doi:10.1111/j.1399-0012.2006.00519.x16842513
  • Crabol Y, Terrier B, Rozenberg F, et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. Clin Infect Dis. 2013;56(7):968–977. doi:10.1093/cid/cis104623243178
  • Garikapati S, Nguyen M. Foscarnet. StatPearls; 2021.
  • Thongprayoon C, Khoury NJ, Bathini T, et al. Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: a meta-analysis. Urol Ann. 2020;12(3):241–247. doi:10.4103/UA.UA_89_1933100749
  • Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006;43(1):40–48. doi:10.1086/50481216758416
  • An HPH, Diem HT, Cuong NT. Parvovirus B19-associated anemia in kidney transplant recipients: a single-center experience. Transplant Proc. 2019;51(8):2693–2696. doi:10.1016/j.transproceed.2019.03.07631351772
  • Gallinella G, Manaresi E, Venturoli S, Grazi GL, Musiani M, Zerbini M. Occurrence and clinical role of active parvovirus B19 infection in transplant recipients. Eur J Clin Microbiol Infect Dis. 1999;18(11):811–813. doi:10.1007/s10096005040610614957
  • Landry ML, Hayden RT, Wolk DM, Carroll KC, Tang Y-W. Parvovirus B19. Microbiol Spectr. 2016;4(3). doi:10.1128/microbiolspec.DMIH2-0008-2015
  • Eid AJ, Chen SF; AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):201–205. doi:10.1111/ajt.1211123465012
  • Plentz A, Wurdinger M, Kudlich M, Modrow S. Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia. J Clin Virol. 2013;58(2):443–448. doi:10.1016/j.jcv.2013.07.00723916377
  • Vo AA, Cam V, Toyoda M, et al. Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience. Clin J Am Soc Nephrol. 2006;1(4):844–852. doi:10.2215/CJN.0170110517699296
  • Deray G, Martinez F, Katlama C, et al. Foscarnet nephrotoxicity: mechanism, incidence and prevention. Am J Nephrol. 1989;9(4):316–321. doi:10.1159/0001679872554731
  • Iwami D, Ogawa Y, Fujita H, et al. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: a case report. Nephrology (Carlton). 2016;21(Suppl 1):63–66. doi:10.1111/nep.1276726970406
  • Kerr JR, Curran MD, Moore JE, Murphy PG. Parvovirus B19 infection–persistence and genetic variation. Scand J Infect Dis. 1995;27(6):551–557. doi:10.3109/003655495090470668685632
  • Cassinotti P, Schultze D, Schlageter P, Chevili S, Siegl G. Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient. Eur J Clin Microbiol Infect Dis. 1993;12(9):701–704. doi:10.1007/BF20093848243488
  • Cassinotti P, Siegl G. Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual. Eur J Clin Microbiol Infect Dis. 2000;19(11):886–887. doi:10.1007/s10096000038411152317

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.